2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Central Nervous System: new trials by email Literature Review of Central Nervous System trials Research Report on Central Nervous System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Switching From ATRIPLA™ (Efavirenz, Tenofovir, Emtricitabine) to MK-1439A (Doravirine, Tenofovir, Lamivudine) in Virologically-Suppressed Participants (MK-1439A-028) Doravirine, Tenofovir, Lamivudine - Blinded, Doravirine, Tenofovir, Lamivudine - Open-Label, ATRIPLA^TM - HIV-1, Central Nervous System | Phase 2 | Completed | Merck Sharp & Dohme LLC | 86 | 2016-03-04 | 2025-02-07 |
| Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs perampanel - Central Nervous System | Phase 2 | Completed | Eisai Inc. | 63 | 2012-01-01 | 2016-07-12 |
Lamivudine (1) · Tenofovir (1) · doravirine (1) · perampanel (1)
Eisai Inc. (1) · Merck Sharp & Dohme LLC (1)
United States (1)
Michelle Gee (1)
2015 (1)